"Radioisotopes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
| Descriptor ID |
D011868
|
| MeSH Number(s) |
D01.496.749
|
| Concept/Terms |
Radioisotopes- Radioisotopes
- Radioactive Isotopes
- Isotopes, Radioactive
- Radionuclides
Daugter Isotopes- Daugter Isotopes
- Isotopes, Daugter
- Radiogenic Isotopes
- Isotopes, Radiogenic
- Daughter Nuclides
- Nuclides, Daughter
|
Below are MeSH descriptors whose meaning is more general than "Radioisotopes".
Below are MeSH descriptors whose meaning is more specific than "Radioisotopes".
This graph shows the total number of publications written about "Radioisotopes" by people in this website by year, and whether "Radioisotopes" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 3 | 4 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 5 | 7 |
| 2002 | 1 | 5 | 6 |
| 2003 | 4 | 3 | 7 |
| 2004 | 1 | 2 | 3 |
| 2005 | 2 | 5 | 7 |
| 2006 | 2 | 2 | 4 |
| 2007 | 4 | 3 | 7 |
| 2008 | 4 | 4 | 8 |
| 2009 | 3 | 4 | 7 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 4 | 6 |
| 2012 | 5 | 5 | 10 |
| 2013 | 5 | 5 | 10 |
| 2014 | 2 | 7 | 9 |
| 2015 | 4 | 4 | 8 |
| 2016 | 4 | 3 | 7 |
| 2017 | 7 | 3 | 10 |
| 2018 | 2 | 6 | 8 |
| 2019 | 5 | 3 | 8 |
| 2020 | 7 | 5 | 12 |
| 2021 | 5 | 8 | 13 |
| 2022 | 4 | 8 | 12 |
| 2023 | 5 | 5 | 10 |
| 2024 | 2 | 10 | 12 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Radioisotopes" by people in Profiles.
-
PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer. Mol Cancer Ther. 2025 Jan 02; 24(1):141-151.
-
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S229-S241.
-
Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy. Eur J Nucl Med Mol Imaging. 2025 Jan; 52(2):458-468.
-
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study. Lancet Oncol. 2024 Oct; 25(10):1267-1276.
-
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol. 2024 Oct; 25(10):1277-1287.
-
Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis. J Nucl Med. 2024 Aug 01; 65(8):1264-1271.
-
CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer. J Nucl Med. 2024 Jul 01; 65(7):1043-1050.
-
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Mol Cancer Ther. 2024 Jun 04; 23(6):890-903.
-
RECIP 1.0 Predicts Progression-Free Survival After [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. J Nucl Med. 2024 Jun 03; 65(6):917-922.
-
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer. Adv Healthc Mater. 2024 Jul; 13(19):e2304618.